These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23312225)

  • 21. Anti-mullerian hormone as a marker of ovarian reserve.
    Tremellen KP; Kolo M; Gilmore A; Lekamge DN
    Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
    Binder H; Strick R; Zaherdoust O; Dittrich R; Hamori M; Beckmann MW; Oppelt PG
    Fertil Steril; 2012 May; 97(5):1169-75.e1. PubMed ID: 22401810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of age-specific serum anti-Müllerian hormone concentrations.
    Barad DH; Weghofer A; Gleicher N
    Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Random anti-Müllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels.
    Buyuk E; Seifer DB; Younger J; Grazi RV; Lieman H
    Fertil Steril; 2011 Jun; 95(7):2369-72. PubMed ID: 21497340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
    Ng EH; Chan CC; Tang OS; Ho PC
    Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro fertilisation treatment and factors affecting success.
    Huang JY; Rosenwaks Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):777-88. PubMed ID: 23059403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome.
    Broer SL; Mol B; Dólleman M; Fauser BC; Broekmans FJ
    Curr Opin Obstet Gynecol; 2010 Jun; 22(3):193-201. PubMed ID: 20407372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-Müllerian hormone--its role in management of involuntary infertility].
    Kalra GS
    Tidsskr Nor Laegeforen; 2009 Feb; 129(5):409-11. PubMed ID: 19247400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian aging and implications for fertility female health.
    Younis JS
    Minerva Endocrinol; 2012 Mar; 37(1):41-57. PubMed ID: 22382614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation.
    Nardo LG; Fleming R; Howles CM; Bosch E; Hamamah S; Ubaldi FM; Hugues JN; Balen AH; Nelson SM
    Reprod Biomed Online; 2011 Aug; 23(2):141-8. PubMed ID: 21665542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Bologna criteria for poor ovarian response: a contemporary critical appraisal.
    Younis JS; Ben-Ami M; Ben-Shlomo I
    J Ovarian Res; 2015 Nov; 8():76. PubMed ID: 26577149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of anti-Müllerian hormone in fertility treatment].
    Pilsgaard F; Grynnerup AG; Løssl K; Pinborg A
    Ugeskr Laeger; 2017 Aug; 179(32):. PubMed ID: 28869028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.
    Appasamy M; Jauniaux E; Serhal P; Al-Qahtani A; Groome NP; Muttukrishna S
    Fertil Steril; 2008 Apr; 89(4):912-21. PubMed ID: 17681319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome.
    Selman H; Pacchiarotti A; El-Danasouri I
    Fertil Steril; 2010 Oct; 94(5):1782-6. PubMed ID: 19939369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
    Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
    Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
    Singer T; Barad DH; Weghofer A; Gleicher N
    Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in antral follicle counts at different times in the menstrual cycle: does it matter?
    Mavrelos D; Al Chami A; Talaulikar V; Burt E; Webber L; Ploubidis G; Yasmin E
    Reprod Biomed Online; 2016 Aug; 33(2):174-9. PubMed ID: 27184084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.